IL7 and head and neck cancer: It has been related to some favorable outcomes as well—IL-7 overexpression correlated with better survival in patients with head and neck cancers [13], improved wound healing [34], milder surgery-induced lymphopenia, and lower incidence of surgical-site infections [24].